TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

United States Biosimilars & Follow-on-biologics Market Research Report 2023

United States Biosimilars & Follow-on-biologics Market Research Report 2023

  • Category:Life Sciences
  • Published on : 02 May 2023
  • Pages :86
  • Formats:
  • Report Code:SMR-7670296

Market Analysis and Insights: Global Biosimilars & Followonbiologics Market

The global Biosimilars & Followonbiologics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biosimilars & Followonbiologics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biosimilars & Followonbiologics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biosimilars & Followonbiologics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biosimilars & Followonbiologics market.

Global Biosimilars & Followonbiologics Scope and Market Size

The United States Biosimilars & Follow-on-biologics market is projected to grow from US$ billion in 2023 to US$ billion by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. This report contains market size and forecasts of Biosimilars & Follow-on-biologics in global, including the following market information: United States Biosimilars & Follow-on-biologics Market Revenue, 2018-2023, 2023-2032, ($ millions) United States Biosimilars & Follow-on-biologics Market Sales, 2018-2023, 2023-2032, United States top five Biosimilars & Follow-on-biologics companies in 2022 (%) The United States Biosimilars & Follow-on-biologics market was valued at million in 2022 and is projected to reach US$ million by 2032, at a CAGR of % during the forecast period 2023-2032. Report Includes This report presents an overview of United States market for Biosimilars & Follow-on-biologics , sales, revenue and price. Analyses of the United States market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2032. This report focuses on the Biosimilars & Follow-on-biologics sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the United States Biosimilars & Follow-on-biologics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. This report analyzes the segments data by Type, and by Sales Channels, sales, revenue, and price, from 2018 to 2032. Evaluation and forecast the market size for Humidifier sales, projected growth trends, production technology, sales channels and end-user industry. Segment by Type Human growth hormone Erythropoietin Monoclonal antibodies Insulin Interferon Granulocyte-Colony Stimulating Factor Others Segment by Applications Blood Disorders Oncology Diseases Chronic and Autoimmune Diseases Growth Hormone Deficiencies Others

Key Companies covered in this report:

  • Company 1
  • Company 2
  • Company 3
  • Company 4
  • Company 5
  • Company 6
  • Company 7
  • Company 8
  • Company 9
  • Company 10
Competitor Analysis The report also provides analysis of leading market participants including: Key companies Biosimilars & Follow-on-biologics revenues in global market, 2018-2023 (Estimated), ($ millions) Key companies Biosimilars & Follow-on-biologics revenues share in global market, 2022 (%) Key companies Biosimilars & Follow-on-biologics sales in global market, 2018-2023 (Estimated), Key companies Biosimilars & Follow-on-biologics sales share in global market, 2022 (%)

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Biosimilars & Followonbiologics product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Biosimilars & Followonbiologics, with price, sales, revenue, and global market share of Biosimilars & Followonbiologics from 2019 to 2022.

Chapter 3, the Biosimilars & Followonbiologics competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Biosimilars & Followonbiologics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Biosimilars & Followonbiologics market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Biosimilars & Followonbiologics.

Chapter 13, 14, and 15, to describe Biosimilars & Followonbiologics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Biosimilars & Followonbiologics Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

TABLE OF CONTENTS

1 STUDY COVERAGE
1.1 Biosimilars & Follow-on-biologics Product Introduction
1.2 Market by Type
1.2.1 United States Biosimilars & Follow-on-biologics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Type1
1.2.3 Type2
1.3 Market by Application1.3.1 United States Biosimilars & Follow-on-biologics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Application 1
1.3.3 Application 2
1.4 United States Biosimilars & Follow-on-biologics Sales Estimates and Forecasts 2017-20281.5 United States Biosimilars & Follow-on-biologics Hydrocephalus Shunts Revenue Estimates and Forecasts 2017-2028
1.6 Study Objectives
1.7 Years Considered

2 COMPETITION BY MANUFACTURERS
2.1 United States Biosimilars & Follow-on-biologics Sales by Manufacturers
2.1.1 United States Biosimilars & Follow-on-biologics Sales by Manufacturers (2017-2022)2.1.2 United States Biosimilars & Follow-on-biologics Sales Market Share by Manufacturers (2017-2022)
2.1.3 Top Largest Manufacturers of Biosimilars & Follow-on-biologics in 2021 in United States2.2 United States Biosimilars & Follow-on-biologics Revenue by Manufacturers
2.2.1 United States Biosimilars & Follow-on-biologics Revenue by Manufacturers (2017-2022)2.2.2 United States Biosimilars & Follow-on-biologics Revenue Market Share by Manufacturers (2017-2022)
2.2.3 United States Top Companies by Biosimilars & Follow-on-biologics Revenue in 20212.3 United States Biosimilars & Follow-on-biologics Sales Price by Manufacturers (2017-2022)
2.4 Analysis of Competitive Landscape
2.4.1 Manufacturers Market Concentration Ratio (CR3 and HHI)2.4.2 United States Biosimilars & Follow-on-biologics by Company Type (Tier 1, Tier 2, and Tier 3)
2.4.3 United States Biosimilars & Follow-on-biologics Manufacturers Geographical Distribution
2.5 Mergers & Acquisitions, Expansion Plans

3 UNITED STATES Biosimilars & Follow-on-biologics MARKET SIZE BY REGION
3.1 Biosimilars & Follow-on-biologics Market Size by Region: 2017-2028
3.1.1 United States Biosimilars & Follow-on-biologics Sales by Region: 2017-20223.1.2 United States Biosimilars & Follow-on-biologics Sales Forecast by Region (2023-2028)
3.1.3 United States Biosimilars & Follow-on-biologics Revenue by Region: 2017-2022
3.1.4 United States Biosimilars & Follow-on-biologics Revenue Forecast by Region (2023-2028)3.2 Northeast Biosimilars & Follow-on-biologics Sales and Revenue Growth (2017-2028)
3.3 South Biosimilars & Follow-on-biologics Sales and Revenue Growth (2017-2028)
3.4 Midwest Biosimilars & Follow-on-biologics Sales and Revenue Growth (2017-2028)3.5 West Biosimilars & Follow-on-biologics Sales and Revenue Growth (2017-2028)

4 MARKET SIZE BY TYPE
4.1 United States Biosimilars & Follow-on-biologics Sales by Type4.1.1 United States Biosimilars & Follow-on-biologics Historical Sales by Type (2017-2022)
4.1.2 United States Biosimilars & Follow-on-biologics Forecasted Sales by Type (2023-2028)
4.1.3 United States Biosimilars & Follow-on-biologics Sales Market Share by Type (2017-2028)4.2 United States Biosimilars & Follow-on-biologics Revenue by Type
4.2.1 United States Biosimilars & Follow-on-biologics Historical Revenue by Type (2017-2022)
4.2.2 United States Biosimilars & Follow-on-biologics Forecasted Revenue by Type (2023-2028)4.2.3 United States Biosimilars & Follow-on-biologics Revenue Market Share by Type (2017-2028)
4.3 United States Biosimilars & Follow-on-biologics Price by Type
4.3.1 United States Biosimilars & Follow-on-biologics Price by Type (2017-2022)4.3.2 United States Biosimilars & Follow-on-biologics Price Forecast by Type (2023-2028)

5 MARKET SIZE BY APPLICATION
5.1 United States Biosimilars & Follow-on-biologics Sales by Application5.1.1 United States Biosimilars & Follow-on-biologics Historical Sales by Application (2017-2022)
5.1.2 United States Biosimilars & Follow-on-biologics Forecasted Sales by Application (2023-2028)
5.1.3 United States Biosimilars & Follow-on-biologics Sales Market Share by Application (2017-2028)5.2 United States Biosimilars & Follow-on-biologics Revenue by Application
5.2.1 United States Biosimilars & Follow-on-biologics Historical Revenue by Application (2017-2022)
5.2.2 United States Biosimilars & Follow-on-biologics Forecasted Revenue by Application (2023-2028)5.2.3 United States Biosimilars & Follow-on-biologics Revenue Market Share by Application (2017-2028)
5.3 United States Biosimilars & Follow-on-biologics Price by Application
5.3.1 United States Biosimilars & Follow-on-biologics Price by Application (2017-2022)5.3.2 United States Biosimilars & Follow-on-biologics Price Forecast by Application (2023-2028)

6 CORPORATE PROFILE
6.1 Company16.1.1 Company 1 Corporation Information
6.1.2 Company 1 Overview
6.1.3 Company 1 in United States: Biosimilars & Follow-on-biologics Sales, Price, Revenue and Gross Margin (2017-2022)6.1.4 Company 1 Biosimilars & Follow-on-biologics Product Introduction
6.1.5 Company 1 Recent Developments
6.2 Company 2
6.2.1 Company 2 Corporation Information
6.2.2 Company 2 Overview6.2.3 Company 2 in United States: Biosimilars & Follow-on-biologics Sales, Price, Revenue and Gross Margin (2017-2022)
6.2.4 Company 2 Biosimilars & Follow-on-biologics Product Introduction
6.2.5 Company 2 Recent Developments
6.3 Company 3
6.3.1 Company 3 Corporation Information6.3.2 Company 3 Overview
6.3.3 Company 3 in United States: Biosimilars & Follow-on-biologics Sales, Price, Revenue and Gross Margin (2017-2022)
6.3.4 Company 3 Biosimilars & Follow-on-biologics Product Introduction
6.3.5 Company 3 Recent Developments
6.4 Company 36.4.1 Company 4 Corporation Information
6.4.2 Company 4 Overview
6.4.3 Company 4 in United States: Biosimilars & Follow-on-biologics Sales, Price, Revenue and Gross Margin (2017-2022)
6.4.4 Company 4 Biosimilars & Follow-on-biologics Product Introduction
6.4.5 Company 4 Recent Developments

7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Biosimilars & Follow-on-biologics Industry Chain Analysis
7.2 Biosimilars & Follow-on-biologics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers7.3 Biosimilars & Follow-on-biologics Production Mode & Process
7.4 Biosimilars & Follow-on-biologics Sales and Marketing
7.4.1 Biosimilars & Follow-on-biologics Sales Channels
7.4.2 Biosimilars & Follow-on-biologics Distributors
7.5 Biosimilars & Follow-on-biologics Customers

8 Biosimilars & Follow-on-biologics MARKET DYNAMICS
8.1.1 Biosimilars & Follow-on-biologics Industry Trends
8.1.2 Biosimilars & Follow-on-biologics Market Drivers
8.1.3 Biosimilars & Follow-on-biologics Market Challenges
8.1.4 Biosimilars & Follow-on-biologics Market Restraints

9 KEY FINDINGS IN THE UNITED STATES Biosimilars & Follow-on-biologics STUDY

10 APPENDIX
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Biosimilars & Follow-on-biologics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Human growth hormone
Table 3. Key Players of Erythropoietin
Table 4. Key Players of Monoclonal antibodies
Table 5. Key Players of Insulin
Table 6. Key Players of Interferon
Table 7. Key Players of Granulocyte-Colony Stimulating Factor
Table 8. Key Players of Others
Table 9. Global Biosimilars & Follow-on-biologics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Biosimilars & Follow-on-biologics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Biosimilars & Follow-on-biologics Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Biosimilars & Follow-on-biologics Market Share by Region (2017-2022)
Table 13. Global Biosimilars & Follow-on-biologics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Biosimilars & Follow-on-biologics Market Share by Region (2023-2028)
Table 15. Biosimilars & Follow-on-biologics Market Trends
Table 16. Biosimilars & Follow-on-biologics Market Drivers
Table 17. Biosimilars & Follow-on-biologics Market Challenges
Table 18. Biosimilars & Follow-on-biologics Market Restraints
Table 19. Global Biosimilars & Follow-on-biologics Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Biosimilars & Follow-on-biologics Market Share by Players (2017-2022)
Table 21. Global Top Biosimilars & Follow-on-biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars & Follow-on-biologics as of 2021)
Table 22. Ranking of Global Top Biosimilars & Follow-on-biologics Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Biosimilars & Follow-on-biologics Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Biosimilars & Follow-on-biologics Product Solution and Service
Table 26. Date of Enter into Biosimilars & Follow-on-biologics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Biosimilars & Follow-on-biologics Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Biosimilars & Follow-on-biologics Revenue Market Share by Type (2017-2022)
Table 30. Global Biosimilars & Follow-on-biologics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Biosimilars & Follow-on-biologics Revenue Market Share by Type (2023-2028)
Table 32. Global Biosimilars & Follow-on-biologics Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Biosimilars & Follow-on-biologics Revenue Market Share by Application (2017-2022)
Table 34. Global Biosimilars & Follow-on-biologics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Biosimilars & Follow-on-biologics Revenue Market Share by Application (2023-2028)
Table 36. North America Biosimilars & Follow-on-biologics Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Biosimilars & Follow-on-biologics Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Biosimilars & Follow-on-biologics Market Size by Country (2017-2022) & (US$ Million)
Table 39. Europe Biosimilars & Follow-on-biologics Market Size by Country (2023-2028) & (US$ Million)
Table 40. Asia-Pacific Biosimilars & Follow-on-biologics Market Size by Region (2017-2022) & (US$ Million)
Table 41. Asia-Pacific Biosimilars & Follow-on-biologics Market Size by Region (2023-2028) & (US$ Million)
Table 42. Latin America Biosimilars & Follow-on-biologics Market Size by Country (2017-2022) & (US$ Million)
Table 43. Latin America Biosimilars & Follow-on-biologics Market Size by Country (2023-2028) & (US$ Million)
Table 44. Middle East & Africa Biosimilars & Follow-on-biologics Market Size by Country (2017-2022) & (US$ Million)
Table 45. Middle East & Africa Biosimilars & Follow-on-biologics Market Size by Country (2023-2028) & (US$ Million)
Table 46. Novartis (Sandoz) Company Detail
Table 47. Novartis (Sandoz) Business Overview
Table 48. Novartis (Sandoz) Biosimilars & Follow-on-biologics Product
Table 49. Novartis (Sandoz) Revenue in Biosimilars & Follow-on-biologics Business (2017-2022) & (US$ Million)
Table 50. Novartis (Sandoz) Recent Development
Table 51. Synthon Pharmaceuticals Company Detail
Table 52. Synthon Pharmaceuticals Business Overview
Table 53. Synthon Pharmaceuticals Biosimilars & Follow-on-biologics Product
Table 54. Synthon Pharmaceuticals Revenue in Biosimilars & Follow-on-biologics Business (2017-2022) & (US$ Million)
Table 55. Synthon Pharmaceuticals Recent Development
Table 56. Teva Pharmaceutical Industries Company Detail
Table 57. Teva Pharmaceutical Industries Business Overview
Table 58. Teva Pharmaceutical Industries Biosimilars & Follow-on-biologics Product
Table 59. Teva Pharmaceutical Industries Revenue in Biosimilars & Follow-on-biologics Business (2017-2022) & (US$ Million)
Table 60. Teva Pharmaceutical Industries Recent Development
Table 61. LG Life Sciences Company Detail
Table 62. LG Life Sciences Business Overview
Table 63. LG Life Sciences Biosimilars & Follow-on-biologics Product
Table 64. LG Life Sciences Revenue in Biosimilars & Follow-on-biologics Business (2017-2022) & (US$ Million)
Table 65. LG Life Sciences Recent Development
Table 66. Celltrion Biocon Company Detail
Table 67. Celltrion Biocon Business Overview
Table 68. Celltrion Biocon Biosimilars & Follow-on-biologics Product
Table 69. Celltrion Biocon Revenue in Biosimilars & Follow-on-biologics Business (2017-2022) & (US$ Million)
Table 70. Celltrion Biocon Recent Development
Table 71. Hospira Company Detail
Table 72. Hospira Business Overview
Table 73. Hospira Biosimilars & Follow-on-biologics Product
Table 74. Hospira Revenue in Biosimilars & Follow-on-biologics Business (2017-2022) & (US$ Million)
Table 75. Hospira Recent Development
Table 76. Merck Serono (Merck) Company Detail
Table 77. Merck Serono (Merck) Business Overview
Table 78. Merck Serono (Merck) Biosimilars & Follow-on-biologics Product
Table 79. Merck Serono (Merck) Revenue in Biosimilars & Follow-on-biologics Business (2017-2022) & (US$ Million)
Table 80. Merck Serono (Merck) Recent Development
Table 81. Biogen idec Company Detail
Table 82. Biogen idec Business Overview
Table 83. Biogen idec Biosimilars & Follow-on-biologics Product
Table 84. Biogen idec Revenue in Biosimilars & Follow-on-biologics Business (2017-2022) & (US$ Million)
Table 85. Biogen idec Recent Development
Table 86. Genentech (Roche) Company Detail
Table 87. Genentech (Roche) Business Overview
Table 88. Genentech (Roche) Biosimilars & Follow-on-biologics Product
Table 89. Genentech (Roche) Revenue in Biosimilars & Follow-on-biologics Business (2017-2022) & (US$ Million)
Table 90. Genentech (Roche) Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biosimilars & Follow-on-biologics Market Share by Type: 2021 VS 2028
Figure 2. Human growth hormone Features
Figure 3. Erythropoietin Features
Figure 4. Monoclonal antibodies Features
Figure 5. Insulin Features
Figure 6. Interferon Features
Figure 7. Granulocyte-Colony Stimulating Factor Features
Figure 8. Others Features
Figure 9. Global Biosimilars & Follow-on-biologics Market Share by Application in 2021 & 2028
Figure 10. Blood Disorders Case Studies
Figure 11. Oncology Diseases Case Studies
Figure 12. Chronic and Autoimmune Diseases Case Studies
Figure 13. Growth Hormone Deficiencies Case Studies
Figure 14. Others Case Studies
Figure 15. Biosimilars & Follow-on-biologics Report Years Considered
Figure 16. Global Biosimilars & Follow-on-biologics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 17. Global Biosimilars & Follow-on-biologics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Biosimilars & Follow-on-biologics Market Share by Region: 2021 VS 2028
Figure 19. Global Biosimilars & Follow-on-biologics Market Share by Players in 2021
Figure 20. Global Top Biosimilars & Follow-on-biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars & Follow-on-biologics as of 2021)
Figure 21. The Top 10 and 5 Players Market Share by Biosimilars & Follow-on-biologics Revenue in 2021
Figure 22. North America Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. North America Biosimilars & Follow-on-biologics Market Share by Country (2017-2028)
Figure 24. United States Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Europe Biosimilars & Follow-on-biologics Market Share by Country (2017-2028)
Figure 28. Germany Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Biosimilars & Follow-on-biologics Market Share by Region (2017-2028)
Figure 36. China Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America Biosimilars & Follow-on-biologics Market Share by Country (2017-2028)
Figure 44. Mexico Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Biosimilars & Follow-on-biologics Market Share by Country (2017-2028)
Figure 48. Turkey Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Saudi Arabia Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Novartis (Sandoz) Revenue Growth Rate in Biosimilars & Follow-on-biologics Business (2017-2022)
Figure 51. Synthon Pharmaceuticals Revenue Growth Rate in Biosimilars & Follow-on-biologics Business (2017-2022)
Figure 52. Teva Pharmaceutical Industries Revenue Growth Rate in Biosimilars & Follow-on-biologics Business (2017-2022)
Figure 53. LG Life Sciences Revenue Growth Rate in Biosimilars & Follow-on-biologics Business (2017-2022)
Figure 54. Celltrion Biocon Revenue Growth Rate in Biosimilars & Follow-on-biologics Business (2017-2022)
Figure 55. Hospira Revenue Growth Rate in Biosimilars & Follow-on-biologics Business (2017-2022)
Figure 56. Merck Serono (Merck) Revenue Growth Rate in Biosimilars & Follow-on-biologics Business (2017-2022)
Figure 57. Biogen idec Revenue Growth Rate in Biosimilars & Follow-on-biologics Business (2017-2022)
Figure 58. Genentech (Roche) Revenue Growth Rate in Biosimilars & Follow-on-biologics Business (2017-2022)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

Offer REPORT BUYING OPTIONS

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Multi User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount